6 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
The obesity epidemic has been framed predominantly through energy balance and diet composition, with less attention to the temporal dimension of food intake. Emerging evidence indicates that meal timing and circadian disruption independently modulate susceptibility to diet-induced obesity. Peripheral clocks in the live...
Chronic kidney disease (CKD) presents a significant clinical challenge for anticoagulation therapy due to the coexistence of elevated thromboembolic risk and increased bleeding tendency. Management is further complicated by altered pharmacokinetics, limited high-quality evidence in advanced CKD, and the systematic excl...
The global prevalence of obesity continues to rise, with 3 billion adults projected to be affected by 2030. Recent advances in anti-obesity pharmacotherapy, particularly incretin-based medications, have transformed obesity management. This consensus provides evidence-based guidelines for the clinical use of incretin-ba...
The future of nephrology will be defined not by a single disruptive innovation, but by the convergence of prevention, precision medicine, digital health, regenerative biology, and advanced kidney replacement technologies.
This structured narrative review aims to synthesize current evidence, assess the relevance of aspirin as a low-cost, scalable intervention within diverse populations and critically evaluate recent guideline changes regarding primary prevention.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
